Evidence map›Paper›PMID 40514253›Full record

ArticleEuropean urology2025

Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification Schemes.

Sam S Chang, Bryn Launer, Vikram Narayan, Dattatraya Patil, Michael A O'Donnell, Patrick J Hensley, John A Taylor, Roger Li, Mario I Fernandez, Haochen Zhang and 15 more

Abstract readLetter
In one paragraph

Article in European urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Sam S ChangDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: sam.chang@vumc.org.
Bryn LaunerDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
Vikram NarayanDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Dattatraya PatilDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Michael A O'DonnellDepartment of Urology, University of Iowa, Iowa City, IA, USA.
Patrick J HensleyDepartment of Urology, University of Kentucky College of Medicine, Lexington, KY, USA.
John A TaylorDepartment of Urology, University of Kansas Medical Center, Kansas City, KS, USA.
Roger LiDepartment of Urology, Moffitt Cancer Center, Tampa, FL, USA.
Mario I FernandezDepartment of Urology, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
Haochen ZhangValar Labs, Palo Alto, CA, USA.
Viswesh KrishnaValar Labs, Palo Alto, CA, USA.
Damir VrabacValar Labs, Palo Alto, CA, USA.
Waleed M AbuzeidValar Labs, Palo Alto, CA, USA.
Vivek NimgaonkarValar Labs, Palo Alto, CA, USA.
Drew WatsonValar Labs, Palo Alto, CA, USA.
Trevor J RoyceValar Labs, Palo Alto, CA, USA.
Lesli A KiedrowskiValar Labs, Palo Alto, CA, USA.
Anirudh JoshiValar Labs, Palo Alto, CA, USA.
Badrinath R KonetyDepartment of Urology, Allina Health, Minneapolis, MN, USA.
Philippe E SpiessDepartment of Urology, Moffitt Cancer Center, Tampa, FL, USA.
Stephen B WilliamsDepartment of Urology, University of Texas Medical Branch, Galveston, TX, USA.
Vignesh T PackiamSection of Urologic Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA.
Ashish M KamatDepartment of Urology, MD Anderson Cancer Center, Houston, TX, USA.
Yair LotanDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Siamak DaneshmandDepartment of Urology, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
NCI NIH HHS P30 CA177558
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40514253
PMCPMC12718547

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.